Average Co-Inventor Count = 2.68
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (68 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (9 from 2,405 patents)
3. Magatti, Charles V. (0 patent)
4. Doll, Ronald J. (0 patent)
5. Gold, Elijah H. (0 patent)
6. Neustadt, Bernard R. (0 patent)
7. Smith, Elizabeth M. (0 patent)
77 patents:
1. 9440952 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
2. 8822480 - Bicyclic heterocycle derivatives and use thereof as GPR119 modulators
3. 8815876 - Bicyclic heterocycle derivatives and methods of use thereof
4. 8722882 - Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes
5. 8435994 - Substituted [1,2,4]triazolo[4,3-alpha]quinoxalines as adenosine A2a receptor antagonists
6. RE44205 - Adenosine Areceptor antagonists
7. 8415353 - [object Object]
8. 8410122 - Bicyclic heterocycle derivatives and methods of use thereof
9. 8318751 - Pyrimidinone derivatives and methods of use thereof
10. 8222259 - [object Object]
11. 8114879 - Piperazine derivatives useful as CCR5 antagonists
12. 7790474 - p53 modulators
13. 7741318 - [object Object]
14. 7709492 - [object Object]
15. 7465740 - 2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists